Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma
Clinical trial NCT03215758 · COMPLETED
Trial details
- NCT number
- NCT03215758
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-01
- Primary completion
- 2019-07-02
- Enrollment
- 675
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.